GMJ TECHNOLOGIES, INC.

Everett, WA · Medtech · Private

Micro SDS depletion electrophoresis interface coupling capillary electrophoresis to mass spectrometry for monoclonal antibody characterization

Claim this profile

Follows are private to you and power your alerts

Updated · gmjtechs.com

Sector
Medtech
Headquarters
Everett, WA
Total capital
$4.4M
Federal grants
$4.4M
6 awards · 2019–2026
Rank in peer group#41 of 112
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
7 pending · first 2022
Rank in peer group#18 of 112

Capital timeline

20192020202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $4.4M$225K$996K$359K$350K$1.6M$902K
2019202120232025FEDERAL ↑EQUITY ↓Cumulative $4.4M$996K$359K$1.6M$902K

Latest events

  • Federal grantHealth and Human S · Phase II · High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics$902K
  • Federal grantHealth and Human S · Phase II · High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics$1.6M
  • Federal grantHealth and Human S · Phase II · High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics$350K
  • Federal grantHealth and Human S · Phase I · Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry$359K
  • Federal grantNSF · Phase II · SBIR Phase II: Next-Generation Capillary Electrophoresis with Mass Spectrometry for Biopharmaceutical and Biomedical Applications$996K
  • Federal grantNSF · Phase I · SBIR Phase I: Next-Generation Capillary Electrophoresis with Mass Spectrometry for Biopharmaceutical and Biomedical Applications$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 112 peers

Line = median

Medtech · Instrument

  • Federal grants#41 · top 37%
  • Granted patents#18 · top 16%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 3 granted of 10
Show all 10 patent records
  • Surface Modified Capillary For Electrophoresis And Method For Construction ThereofSep 18, 2025 · Application 19079159Pending
  • Methods For Protein-sds Complex Decoupling For Protein Mass Spectrometry AnalysisSep 18, 2025 · Application 19076283Pending
  • Interface For Electrospray Ionization (esi) In Capillary Electrophoresis With Mass SpectrometryJan 21, 2025 · US 12,205,812Granted
  • Apparatuses For Optical And Mass Spectrometry DetectionJun 13, 2023 · US 11,676,807Granted
  • Apparatuses For Optical And Mass Spectrometry DetectionJan 11, 2022 · US 11,222,779Granted
  • Liquid Handling Devices And Methods In Capillary ElectrophoresisAug 26, 2021 · Application 17251500Pending
  • Method For Capillary Modification And A Modified Capillary ThereofApplication 63564858Pending
  • Methods For Protein-sds Complex Decoupling For Protein Mass Spectrometry AnalysisApplication 63564871Pending
  • Protein-sds Complex Decoupling For Protein Mass Spectrometry AnalysisApplication PCTUS2025019396Pending
  • Surface Modified Capillary For Electrophoresis And Method For Construction ThereofApplication PCTUS2025019820Pending
  • GMJ TECHNOLOGIES, LLCShares a founder: OLUWATOSIN DADA
  • Dura LLCSimilar federal contract value in Medtech · null in contracts
  • CAPELLA IMAGING, LLCSimilar federal contract value in Medtech · null in contracts
  • METEORA3D, INCORPORATEDSimilar federal contract value in Medtech · null in contracts
  • IMPEDX DIAGNOSTICS, INC.Similar federal contract value in Medtech · null in contracts
  • Amplified Sciences, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .